Publications
- Treatment with pembrolizumab in a patient with non-small cell lung cancer after a faecal transplantation - case report2023 | First Faculty of Medicine, Third Faculty of Medicine
- Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Can Previous Chemotherapy Affect the Outcome of Nivolumab Treatment in Non-small Cell Lung Cancer?2022 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Two years longer and peaceful life thanks to alectinib2022 | Third Faculty of Medicine, Central Library of Charles University
- Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Lorlatinib in a pretreated patient with ALK-positive lung adenocarcinoma2021 | Third Faculty of Medicine
- Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry2020 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Effect of clinical parameters on second- and third-line erlotinib treatment of EGFR wild type patients with advanced NSCLC2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Second Faculty of Medicine
- Efficacy of erlotinib in subsequent lines of non-small cell lung cancer therapy2018 | Third Faculty of Medicine
- Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...